SAN DIEGO -- Treatment with an investigational oral inhibitor of Bruton's tyrosine kinase (BTK) was safe and boosted platelet ...
IVIG prophylaxis led to improvements in infection-free survival as well as progression free and overall survival in patients ...
Novartis (NVS) announced “positive,” longer-term results from the pivotal Phase 3 ASC4FIRST trial with Scemblix showing superior major ...
Scemblix demonstrated sustained superior major molecular response (MMR) vs. all investigator-selected TKIs (74.1% vs. 52%) and vs. imatinib alone (76.2% vs. 47.1%), meeting both ASC4FIRST 96-week key ...
Firms run as networks of competence tend to grow faster and have higher staff engagement then firms run as hierarchies of ...
Deal-making featured strongly among last week’s news, first with PCT Therapeutics inking an up to 2.9 billion collaboration ...
High cholesterol can go undetected until levels are far too high, resulting in many peoples first sign of the disease being a ...
Both countries are also key global players in life sciences - with the UK's life sciences sector worth £108 billion, and ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
The global peptide drug conjugates market is on an unprecedented growth trajectory, with market value projected to leap from ...
Genmab's royalty revenues are expected to exceed $2.5 billion this year and potentially $4 billion at peak. See why I rate ...
Cooking gas dealers have debunked allegations of underfills by retailers, saying that many factors contribute to fast ...